Product Wiki · Recalls · Health Canada Consumer Product Safety

Recall 81478 — All strengths of Teva Octreotide for Injectable Suspension Kit (DIN 02503751, 02503778 and 0253786) with the lot numbers noted below.

Health Canada Consumer Product Safety · Canada · 2026-01-13

AI-assisted, human-edited — this page is drafted with AI from public-source data, then reviewed before publication. How we use AI →

Agency: Health Canada Consumer Product Safety
Recall identifier: 81478
Date of alert: 2026-01-13
Country / jurisdiction: Canada
Risk type: recall
Product category: Drugs
Product type: Communications and Public Affairs Branch
Barcode (EAN/GTIN): 02503751

Reported risk: Product quality

Primary source: https://recalls-rappels.canada.ca/en/alert-recall/teva-octreotide-injectable-sus

Verify each fact at the issuing agency before acting. Recall scope, affected lots, and remediation instructions may be updated by the agency after our last sync.

ProductGuru indexes recall and safety-alert records from ~30 public agency registries. We are not lawyers, regulators or product-safety consultants. This page restates what the named agency published; consult the primary source above (or qualified counsel in your jurisdiction) before any commercial, medical or safety decision.

Recall 81478 — All strengths of Teva Octreotide for Injectable Suspension Kit (DIN 02503751, 02503778 and 0253786) with the lot numbers noted below.

Related